Cue Biopharma, Inc.
NASDAQ:CUEBiotechnology
Healthcare
$14.10 +1.42%
+$0.38 today
- Market cap
- $102.43M
- Beta
- 2.53
- P/E (TTM)
- -6.7
- EPS (TTM)
- -$4.06
52W Low $4.98High $41.42
Volume 0.21M
Average 0.74M
Price history
Cue Biopharma, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-13.07%
Period high
$37.84
Period low
$5.31
Latest
$14.10
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G/A | Nov 10, 2026 | Nov 10, 2026 | |
| 4 | Oct 14, 2026 | Oct 14, 2026 | |
| 4 | Oct 14, 2026 | Oct 14, 2026 | |
| 4 | Oct 14, 2026 | Oct 14, 2026 | |
| SC 13G/A | Oct 8, 2026 | Oct 8, 2026 | |
| 8-K | Sep 21, 2026 | Sep 21, 2026 | |
| 4/A | Aug 28, 2026 | Aug 28, 2026 | |
| 4/A | Aug 28, 2026 | Aug 28, 2026 | |
| SC 13D | Aug 21, 2026 | Aug 21, 2026 | |
| EFFECT | Aug 20, 2026 | Aug 21, 2026 | |
| 4 | Aug 17, 2026 | Aug 17, 2026 | |
| 4 | Aug 17, 2026 | Aug 17, 2026 | |
| 8-K | Aug 14, 2026 | Aug 14, 2026 | |
| 10-Q | Aug 14, 2026 | Aug 14, 2026 | |
| 4 | Aug 14, 2026 | Aug 14, 2026 |
Competitors
Who does Cue Biopharma, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about CUE's filings, answered from its disclosures.
What is the latest CUE filing?
The latest filing shown is SC 13G/A dated Nov 10, 2026.
How many recent filings does CUE have?
Intrinsic Alpha currently shows 20 recent filings for CUE.
Continue the stock analysis
Jump to another research area for this company.